Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pLenti CMV/TO Neo DEST (685-3) Citations (13)

Originally described in: A versatile viral system for expression and depletion of proteins in mammalian cells.
Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. PLoS One. 2009 Aug 6;4(8):e6529.
PubMed Journal

Articles Citing pLenti CMV/TO Neo DEST (685-3)

A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells. Birket MJ, Orr AL, Gerencser AA, Madden DT, Vitelli C, Swistowski A, Brand MD, Zeng X. J Cell Sci. 2011 Feb 1;124(Pt 3):348-58. doi: 10.1242/jcs.072272. PubMed
Necdin modulates proliferative cell survival of human cells in response to radiation-induced genotoxic stress. Lafontaine J, Tchakarska G, Rodier F, Mes-Masson AM. BMC Cancer. 2012 Jun 12;12:234. doi: 10.1186/1471-2407-12-234. PubMed
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Strom CE, Svensson LM, Schultz N, Lundback T, Einarsdottir BO, Saleh A, Gokturk C, Baranczewski P, Svensson R, Berntsson RP, Gustafsson R, Stromberg K, Sanjiv K, Jacques-Cordonnier MC, Desroses M, Gustavsson AL, Olofsson R, Johansson F, Homan EJ, Loseva O, Brautigam L, Johansson L, Hoglund A, Hagenkort A, Pham T, Altun M, Gaugaz FZ, Vikingsson S, Evers B, Henriksson M, Vallin KS, Wallner OA, Hammarstrom LG, Wiita E, Almlof I, Kalderen C, Axelsson H, Djureinovic T, Puigvert JC, Haggblad M, Jeppsson F, Martens U, Lundin C, Lundgren B, Granelli I, Jensen AJ, Artursson P, Nilsson JA, Stenmark P, Scobie M, Berglund UW, Helleday T. Nature. 2014 Apr 10;508(7495):215-21. doi: 10.1038/nature13181. Epub 2014 Apr 2. PubMed
Oncogene-like induction of cellular invasion from centrosome amplification. Godinho SA, Picone R, Burute M, Dagher R, Su Y, Leung CT, Polyak K, Brugge JS, Thery M, Pellman D. Nature. 2014 Jun 5;510(7503):167-71. doi: 10.1038/nature13277. Epub 2014 Apr 13. PubMed
Generation and characterization of an immortalized human mesenchymal stromal cell line. Skarn M, Noordhuis P, Wang MY, Veuger M, Kresse SH, Egeland EV, Micci F, Namlos HM, Hakelien AM, Olafsrud SM, Lorenz S, Haraldsen G, Kvalheim G, Meza-Zepeda LA, Myklebost O. Stem Cells Dev. 2014 Oct 1;23(19):2377-89. doi: 10.1089/scd.2013.0599. Epub 2014 Jun 30. PubMed
MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition. Liu X, Dong R, Jiang Z, Wei Y, Li Y, Wei L, Sun H, Li Y, Yang N, Yang Q, Liu Z, Kong B. Tumour Biol. 2015 Jan 16. PubMed
Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1. Diamond MI, Cai S, Boudreau A, Carey CJ Jr, Lyle N, Pappu RV, Swamidass SJ, Bissell M, Piwnica-Worms H, Shao J. J Biol Chem. 2015 Apr 3;290(14):9075-86. doi: 10.1074/jbc.M114.619874. Epub 2015 Feb 13. PubMed
Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer. Andretta E, Carton-Garcia F, Martinez-Barriocanal A, de Marcondes PG, Jimenez-Flores LM, Macaya I, Bazzocco S, Bilic J, Rodrigues P, Nieto R, Landolfi S, Ramon Y Cajal S, Schwartz S, Brown A, Dopeso H, Arango D. Sci Rep. 2017 Feb 7;7:41576. doi: 10.1038/srep41576. PubMed
Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells. Rhys AD, Monteiro P, Smith C, Vaghela M, Arnandis T, Kato T, Leitinger B, Sahai E, McAinsh A, Charras G, Godinho SA. J Cell Biol. 2018 Jan 2;217(1):195-209. doi: 10.1083/jcb.201704102. Epub 2017 Nov 13. PubMed
SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis. Young LC, Hartig N, Boned Del Rio I, Sari S, Ringham-Terry B, Wainwright JR, Jones GG, McCormick F, Rodriguez-Viciana P. Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10576-E10585. doi: 10.1073/pnas.1720352115. Epub 2018 Oct 22. PubMed
Aberrant Induction of a Mesenchymal/Stem Cell Program Engages Senescence in Normal Mammary Epithelial Cells. Bryson BL, Tamagno I, Taylor SE, Parameswaran N, Chernosky NM, Balasubramaniam N, Jackson MW. Mol Cancer Res. 2021 Apr;19(4):651-666. doi: 10.1158/1541-7786.MCR-19-1181. Epub 2020 Dec 22. PubMed
Development and Initial Characterization of Cellular Models for COG Complex-Related CDG-II Diseases. Sumya FT, Pokrovskaya ID, Lupashin V. Front Genet. 2021 Sep 17;12:733048. doi: 10.3389/fgene.2021.733048. eCollection 2021. PubMed
Inactivation of the Hippo tumor suppressor pathway promotes melanoma. Vittoria MA, Kingston N, Kotynkova K, Xia E, Hong R, Huang L, McDonald S, Tilston-Lunel A, Darp R, Campbell JD, Lang D, Xu X, Ceol CJ, Varelas X, Ganem NJ. Nat Commun. 2022 Jun 29;13(1):3732. doi: 10.1038/s41467-022-31399-w. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.